CF Benchmarks are excited to bring you our successful digital asset podcasts where we discuss the latest crypto insights and crypto news, available on Spotify, Apple Podcasts and Google Podcasts.
Listen to our Head of Content, Ken Odeluga and Lead Research Analyst, Gabe Selby, CFA talk with influential figures from across crypto and the wider world of finance about what’s driving digital assets - from market trends and macroeconomics to crypto protocols, fund flows, on-chain metrics, and more.
Listen here for the latest informed conversation.



CF Benchmarks are the first and leading digital asset index provider, authorized and regulated by the UK FCA. Respected and innovative financial institutions use our indices and reference rates to power regulated financial instruments, like listed derivatives, investment funds, hedge funds and structured products.
The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell any of the underlying instruments cited including but not limited to cryptoassets, financial instruments or any instruments that reference any index provided by CF Benchmarks Ltd. This communication is not intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. Please contact your financial adviser or professional before making an investment decision.
Note: Some of the underlying instruments cited within this material may be restricted to certain customer categories in certain jurisdictions.
Notice of the Demising of CF IoTeX-Dollar Spot Rate

CF Benchmarks
Hyperliquid returns ~83 cents of every fee dollar to HYPE holders via buybacks, far more than Coinbase or Robinhood turn into profit. On fully diluted supply it trades near 61x earnings; our modeling assumes growing market share and puts fair value near $106, about 89% above the June 10 price.

Mark Pilipczuk
Announcement of Consultation on Changes to the CME CF Real Time Indices Methodology

CF Benchmarks
By clicking Accept, you consent to CF Benchmarks's use of cookies.
Visit Cookie Settings to learn how CF Benchmarks uses cookies and to adjust your preferences.